Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Amortization of Deferred Charges (2017 - 2020)

Historic Amortization of Deferred Charges for Forte Biosciences (FBRX) over the last 4 years, with Q1 2020 value amounting to $654000.0.

  • Forte Biosciences' Amortization of Deferred Charges rose 36056.34% to $654000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $2.2 million, marking a year-over-year increase of 9117.65%. This contributed to the annual value of $1.7 million for FY2019, which is 4625.32% up from last year.
  • Forte Biosciences' Amortization of Deferred Charges amounted to $654000.0 in Q1 2020, which was up 36056.34% from $57000.0 recorded in Q4 2019.
  • Forte Biosciences' Amortization of Deferred Charges' 5-year high stood at $1.4 million during Q3 2019, with a 5-year trough of $57000.0 in Q4 2019.
  • Over the past 4 years, Forte Biosciences' median Amortization of Deferred Charges value was $147000.0 (recorded in 2017), while the average stood at $315615.4.
  • Over the last 5 years, Forte Biosciences' Amortization of Deferred Charges had its largest YoY gain of 84755.24% in 2019, and its largest YoY loss of 8016.53% in 2019.
  • Quarter analysis of 4 years shows Forte Biosciences' Amortization of Deferred Charges stood at $149000.0 in 2017, then dropped by 2.68% to $145000.0 in 2018, then crashed by 60.69% to $57000.0 in 2019, then soared by 1047.37% to $654000.0 in 2020.
  • Its last three reported values are $654000.0 in Q1 2020, $57000.0 for Q4 2019, and $1.4 million during Q3 2019.